Director/PDMR Shareholding

RNS Number : 7826R
FireAngel Safety Technology Group
02 July 2020
 

 

 

2 July 2020

 

 

FireAngel Safety Technology Group plc

('FireAngel', the 'Company' or the 'Group')

 

Director's Dealing

 

FireAngel (AIM: FA.), one of Europe's leading developers and suppliers of home safety products, was notified on 1 July 2020 that John Conoley, Executive Chairman, had on the same day purchased 25,000 ordinary shares of 2 pence each in the Company ('Ordinary Shares') at a price of 14.53 pence per share.  As a result, Mr Conoley (and his wife), now have a total beneficial interest, in aggregate, of 374,695 Ordinary Shares, representing 0.30 per cent. of the Company's issued share capital.

 

As a result, under the Company's Share Matching Scheme, John Conoley will be awarded options to subscribe for 25,000 new ordinary shares at 2 pence per share.

 

For further information, please contact:

 

FireAngel Safety Technology Group plc

024 7771 7700

John Conoley, Executive Chairman


Mike Stilwell, Group Finance Director




Shore Capital (Nominated adviser and broker)

020 7408 4050

Tom Griffiths

David Coaten


 

Notes to Editors

 

About FireAngel Safety Technology Group plc

 

FireAngel's mission is to protect, save and improve our customers' lives by making innovative, leading-edge technology simple and accessible.  FireAngel is one of the market leaders in the European home safety products market.

 

FireAngel's principal products are connected smoke alarms, CO alarms, heat alarms and accessories.  The Company has an extensive portfolio of patented intellectual property in Europe, the US and other selected territories.  Products are sold under FireAngel's leading brands of FireAngel, FireAngel Pro, FireAngel Specification and AngelEye.

 

For further product information, please visit: www.fireangeltech.com.

 

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHDGGDRUGGDGGB
UK 100

Latest directors dealings